Dashboard
Manage Tickers

TCRX


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

tscan-therapeutics-to-present-new-research-on-t-cell-therapies-at-acr-convergence-2025-in-chicago
TScan Therapeutics To Present New Research...
09/17/2025 11:03:34

TScan Therapeutics, Inc. (NASDAQ:TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (T...

tscan-therapeutics-q2-eps-028-inline-sales-3076m-beat-1405m-estimate
TScan Therapeutics Q2 EPS $(0.28), Inline,...
08/12/2025 11:12:59

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.28) per share which met the analyst consensus estimate. This ...

what-analysts-are-saying-about-tscan-therapeutics-stock
What Analysts Are Saying About TScan Thera...
05/07/2025 13:00:52

hc-wainwright--co-maintains-buy-on-tscan-therapeutics-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on TScan...
05/07/2025 12:26:11

HC Wainwright & Co. analyst Andres Maldonado maintains TScan Therapeutics (NASDAQ:TCRX) with a Buy and lowers the price ...

tscan-therapeutics-q1-eps-026-beats-029-estimate-sales-217m-beat-110m-estimate
TScan Therapeutics Q1 EPS $(0.26) Beats $(...
05/06/2025 11:03:30

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(...

tscan-therapeutics-to-present-at-the-american-society-of-gene-and-cell-therapy-28th-annual-meeting
TScan Therapeutics To Present At The Ameri...
04/28/2025 20:57:35

expert-outlook-tscan-therapeutics-through-the-eyes-of-5-analysts
Expert Outlook: TScan Therapeutics Through...
04/08/2025 13:00:30

needham-reiterates-buy-on-tscan-therapeutics-maintains-9-price-target
Needham Reiterates Buy on TScan Therapeuti...
04/08/2025 12:46:28

Needham analyst Gil Blum reiterates TScan Therapeutics (NASDAQ:TCRX) with a Buy and maintains $9 price target.

barclays-maintains-overweight-on-tscan-therapeutics-lowers-price-target-to-3
Barclays Maintains Overweight on TScan The...
03/07/2025 11:29:41

Barclays analyst Peter Lawson maintains TScan Therapeutics (NASDAQ:TCRX) with a Overweight and lowers the price target from ...

breaking-down-tscan-therapeutics-4-analysts-share-their-views
Breaking Down TScan Therapeutics: 4 Analys...
03/06/2025 12:00:25

hc-wainwright--co-reiterates-buy-on-tscan-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on TSca...
03/06/2025 11:59:37

HC Wainwright & Co. analyst Andrew Fein reiterates TScan Therapeutics (NASDAQ:TCRX) with a Buy and maintains $15 price t...

needham-maintains-buy-on-tscan-therapeutics-lowers-price-target-to-9
Needham Maintains Buy on TScan Therapeutic...
03/05/2025 16:36:31

Needham analyst Gil Blum maintains TScan Therapeutics (NASDAQ:TCRX) with a Buy and lowers the price target from $11 to $9.

tscan-therapeutics-q4-2024-gaap-eps-030-misses-027-estimate-sales-66500k-miss-135m-estimate-cash-cash-equivalents-and-marketable-securities-of-2901m-to-fund-operations-into-q1-of-2027
TScan Therapeutics Q4 2024 GAAP EPS $(0.30...
03/05/2025 12:12:12

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of ...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/26/2024 21:05:44

why-is-tscan-therapeutics-stock-gaining-today
Why Is TScan Therapeutics Stock Gaining To...
12/26/2024 13:17:12

TScan Therapeutics' stock rises after announcing a $30 million financing deal with Lynx1, extending its cash runway into 2027.

Core News & Articles
Market-Moving News for December 26th
12/26/2024 12:16:10

ZCAR: 193% | Zoomcar Reports 43% Booking Surge, Revamps Website Ahead of Holiday Rush ADD: 161% | Color Star Technology Says Sh...

tscan-therapeutics-enters-securities-purchase-agreement-with-lynx1-capital-investment-fund-advised-by-lynx1-for-sale-of-30m-of-pre-funded-warrants-to-buy-up-to-aggregate-of-750m-shares-of-voting-common-stock-at-400-per-pre-funded-warrant
TScan Therapeutics Enters Securities Purch...
12/26/2024 12:03:29

the-analyst-landscape-5-takes-on-tscan-therapeutics
The Analyst Landscape: 5 Takes On TScan Th...
12/11/2024 14:01:36

hc-wainwright--co-reiterates-buy-on-tscan-therapeutics-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on TSca...
12/11/2024 13:15:47

HC Wainwright & Co. analyst Andrew Fein reiterates TScan Therapeutics (NASDAQ:TCRX) with a Buy and maintains $15 price t...

needham-reiterates-buy-on-tscan-therapeutics-maintains-11-price-target
Needham Reiterates Buy on TScan Therapeuti...
12/11/2024 13:14:47

Needham analyst Gil Blum reiterates TScan Therapeutics (NASDAQ:TCRX) with a Buy and maintains $11 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION